Net Loss Per Share (Tables)

6 Months Ended

Jun. 30, 2020

Net Loss Per Share

Schedule of reconciliation of net loss

	For the Three Months Ended				For the Six Months Ended
	June 30,				June 30,
	2020		2019		2020		2019
Net loss	$	(4,536,818)	$	(4,944,905)	$	(10,910,238)	$	(10,763,986)
Net loss - Non-controlling interest		(82,388)		(174,035)		(163,702)		(277,640)
Net loss attributable to Heat Biologics, Inc.	$	(4,454,430)	$	(4,770,870)	$	(10,746,536)	$	(10,486,346)
Weighted-average number of common shares used in net loss per share attributable to common stockholders —basic and diluted		87,930,846		33,255,724		72,606,461		33,240,529
Net loss per share attributable to Heat Biologics, Inc —basic and diluted	$	(0.05)	$	(0.14)	$	(0.15)	$	(0.32)

Schedule of potentially dilutive securities

	2020	2019
Outstanding stock options	5,592,436	3,008,754
Restricted stock subject to forfeiture and restricted stock units	2,025,215	838,679
Outstanding common stock warrants	5,746,564	9,030,730